Singapore, May 25 -- US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists to generate reliable interaction data faster, as drug discovery grows more complex.

The new Biacore 8S and Biacore 8S+ systems bring together rapid screening and high-quality molecular characterisation in a single system, reducing hands-on time through integrated plate handling, automated workflows, and extended unattended operation, without compromising data quality.

Tim Bervoets, President, Discovery & Medical, Cytiva, says, "Scientists are being asked to move faster while working with increasingly complex molecules and tighter resources. The next generation of Biacore 8 series systems is...